Sökning: onr:"swepub:oai:DiVA.org:liu-133688" >
Human papillomaviru...
-
Wang, ZThe Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden
(författare)
Human papillomavirus antibody responses among patients with incident cervical carcinoma.
- Artikel/kapitelEngelska1997
Förlag, utgivningsår, omfång ...
-
John Wiley & Sons,1997
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-133688
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-133688URI
-
https://doi.org/10.1002/(SICI)1096-9071(199708)52:4<436::AID-JMV16>3.0.CO;2-EDOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:1948502URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
The human papillomavirus (HPV) is recognized as a major cause of cervical cancer precursor lesions. HPV serology is a key method in the continuing elucidation of the importance of HPV exposure for cancer development and in predicting HPV-associated diseases. To extend previous HPV serological studies on cervical cancer, serum samples from a consecutive series of 216 women with incident untreated cervical carcinoma and 243 age- and sex-matched healthy blood donors were evaluated for the presence of antibodies against HPV capsids, a marker of past or present HPV exposure, as well as against several cervical cancer-associated defined HPV epitopes. Among the capsid antibody responses, HPV type 16 seropositivity had the strongest association with cervical cancer (OR 2.7, 95% CI 1.8-4.2), but HPV 18 and HPV 33 seropositivities were also significantly associated with cervical cancer (OR 1.6, 95% CI 1.1-2.5; and OR 1.5, 95% CI 1.0-2.2, respectively). The antibody responses against the defined HPV epitopes were confirmed to be associated with cervical cancer, at ORs ranging from 1.4 to 2.0. In conclusion, the study confirms that antibodies against defined HPV epitopes are associated with cervical cancer and provides evidence that seropositivities for HPV types 16, 18, and 33 are associated with cervical cancer risk.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Konya, JThe Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden
(författare)
-
Åvall Lundkvist, ElisabethDepartment of Gynecologic Oncology, Karolinska Institute, Stockholm, Sweden(Swepub:liu)eliav51
(författare)
-
Sapp, MDepartment of Medical Microbiology, University of Mainz, Mainz, Germany
(författare)
-
Dillner, JKarolinska Institutet
(författare)
-
Dillner, LKarolinska Institutet
(författare)
-
AvallLundkvist, E
(författare)
-
The Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, SwedenDepartment of Gynecologic Oncology, Karolinska Institute, Stockholm, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of Medical Virology: John Wiley & Sons52:40146-66151096-9071
Internetlänk
Hitta via bibliotek
Till lärosätets databas